Tirzepatide Pen

Tirzepatide Pen is a prescription dual GIP and GLP-1 receptor agonist delivery device used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is supplied as a sterile prefilled pen for convenient once-weekly subcutaneous administration. The pen is designed to provide accurate, reliable, and user-friendly dose delivery.

BUY NOW

Category

Tirzepatide Pen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The prefilled injection pen is engineered for precise subcutaneous administration, offering consistent once-weekly dosing and dependable therapeutic performance across multiple dosage strengths. Manufactured under stringent pharmaceutical quality standards, the sterile pen ensures reliable medication delivery while eliminating the need for manual dose preparation. Tirzepatide Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Tirzepatide Pen
Active Ingredient Tirzepatide
Dosage Form Sterile Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Tirzepatide Pen, Tirzepatide Injection Pen, Tirzepatide Prefilled Pen, Weekly Tirzepatide Pen, GIP GLP-1 Injection Pen, Diabetes Injection Pen, Weight Management Injection Pen